EXUS yields 0.04% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, EXUS + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EXUS + PFE for your $10,000?
The Macquarie Focused International Core ETF (EXUS) is a passively managed exchange-traded fund that tracks the MSCI World ex USA Index, providing diversified exposure to large- and mid-cap stocks outside the United States. The fund’s portfolio is heavily weighted toward the finance sector (approximately 26%) and health technology (about 10%), with the majority of assets located in Europe (59%), followed by Asia (22%) and North America (11%). Top holdings include SAP SE and ASML Holding NV. EXUS has seen strong asset growth, with assets under management reaching $2.93 billion and a one-year price performance increase of 15.64%. The ETF does not pay dividends and has a low expense ratio of 0.15%. Shares are issued by Deutsche Bank AG under the Xtrackers brand, and the fund was launched on March 6, 2024.
Full EXUS Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.